Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Broome JD (1981) L-asparaginase: discovery and development as a tumor-inhibitory agent. Cancer Treat Rep 65 (Suppl 4): 111–114
Prager MD, Bachynsky N (1968) Asparagine synthetase in asparagine resistant and susceptible mouse lymphomas. Biochem Biophys Res Commun 31: 43–47
Horowitz B, Madras BK, Meister A, Old LJ, Boyse EA, Stockert E (1968) Asparagine synthetase activity of mouse leukemias. Science 160: 533–535
Prager MD, Bachynsky N (1968) Asparagine synthetase in normal and malignant tissues; correlation with tumor sensitivity to asparagi-nase. Arch Biochem Biophys 127: 645–654
Haskell CM, Canellos GP, Leventhal BG, Carbone PP, Block JB (1969) L-asparaginase resistance in human leukemia-Asparagine synthetase. Biochem Pharmacol 18: 2578–2580
Horowitz B, Meister A (1972) Glutamine-dependent asparagine synthetase from leukemia cells: chloride dependence, mechanism of action, and inhibition. J Biol Chem 247: 6708–6719
Capizzi RL,Holcenberg JS (1993) Asparaginase. In Holland JF, Frei III E, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR, eds. Cancer medicine. Philadelphia and London, Lea & Febiger,796–803
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275
Hongo S, Sato T (1984) Inhibition of rat liver asparagine synthetase by Cibacron Blue F3GA. Enzyme 31: 181–186
Unnithan S, Moraga DA, Schuster SM (1984) A high-performance liquid chromatography assay for asparagine synthetase. Anal Biochem 136: 195–201
Boos J, Werber G, Ahlke E, Schulze-Westhoff P, Nowak-Göttl U, Wörthwein G, Verspohl EJ, Ritter J, Jürgens H (1996) Monitoring of asparagi-nase activity and asparagine levels in children on different asparaginase preparations. Eur J Cancer 32A: 1544–1550
Koishi T, Minowada J, Henderson ES, Ohnuma T (1984) Distinctive sensitivity of some T-leukemia cell-lines to L-asparaginase. GANN 75: 275–283
Kiriyama Y, Kubota M, Takimoto T, Kitoh T, Tanizawa A,Akiyama Y, Mikawa H (1989) Biochemical characterization of U937 cells resistant to Lasparaginase: the role of asparagine synthetase. Leukemia 3: 294–297
Banerjee SP, Gallmeier WM, Schmidt CG (1970) Bestimmung der Asparagin-Synthetase in Leukämiezellen als Indikator für die Enzymtherapie von Hämoblastosen. Deutsche Medizinische Wochenzeitschrift 18: 994–997
Hongo S, Sakagami H, Sato T (1990) Decrease in asparagine synthetase activity during cell differentiation of mouse and human leukemia cell lines. Leukemia 4: 708–711
Kaspers GJ, Pieters R, Van Zantwijk CH, De Laat PA, De Waal FC, Van Wering ER, Veerman AJ (1991) In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. Br J Cancer 64: 469–474
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dübbers, A., Schulze-Westhoff, P., Kurzknabe, E., Creutzig, U., Ritter, J., Boos, J. (1998). Asparagine Synthetase in Pediatric Acute Leukemias: AML-M5 Subtype Shows Lowest Activity. In: Hiddemann, W., et al. Acute Leukemias VII. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71960-8_70
Download citation
DOI: https://doi.org/10.1007/978-3-642-71960-8_70
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71962-2
Online ISBN: 978-3-642-71960-8
eBook Packages: Springer Book Archive